Show simple item record

dc.contributor.authorKucukevcilioglu, Murat
dc.contributor.authorEren, Mustafa
dc.contributor.authorYolcu, Umit
dc.contributor.authorSobaci, Gungor
dc.date.accessioned2019-12-12T06:44:07Z
dc.date.available2019-12-12T06:44:07Z
dc.date.issued2015
dc.identifier.issn0004-2749
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20150030
dc.identifier.urihttp://hdl.handle.net/11655/16852
dc.description.abstractA 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex (R)) implantation for posterior uveitis in the left eye. Varicella zoster virus (VZV) DNA was detected in the anterior chamber and vitreous samples on polymerase chain reaction (PCR) analysis. Retinal detachment occurred despite systemic and intravitreal antiviral therapy. Favorable structural and functional outcomes were achieved after retinal surgery with silicone oil. To the authors' knowledge, this is the first reported case of acute retinal necrosis following placement of an Ozurdex (R) implant. Physicians practicing Ozurdex (R) implantations should be aware of this unusual but devastating complication. Extra caution and frequent follow-up are required in all immunocompromised patients receiving Ozurdex (R) implantation.
dc.language.isoen
dc.publisherConsel Brasil Oftalmologia
dc.relation.isversionof10.5935/0004-2749.20150030
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectOphthalmology
dc.titleAcute Retinal Necrosis Following Intravitreal Dexamethasone (Ozurdex (R)) Implant
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalArquivos Brasileiros De Oftalmologia
dc.contributor.departmentGöz Hastalıkları
dc.identifier.volume78
dc.identifier.issue2
dc.identifier.startpage118
dc.identifier.endpage119
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record